NFL Biosciences
Biopharmaceutical company developing innovative botanical drugs for addiction treatment.
About
Technology stack
detected 2026-06-18No comments yet. Be the first to share your take.
What does NFL Biosciences do?
NFL Biosciences develops botanical drugs to treat addictions, focusing on tobacco, alcohol, and cannabis. Their pipeline includes innovative drug candidates like NFL-101 and NFL-102 for smoking cessation, and NFL-301 for excessive alcohol consumption, aiming to license these to pharmaceutical laboratories. The company leverages scientific expertise in botanical medicines and conducts preclinical and clinical studies. (formerly [].)
How much funding has NFL Biosciences raised?
NFL Biosciences has raised a total of $16M in funding. The most recent round on record is Bond Financing.
Where is NFL Biosciences headquartered?
NFL Biosciences is headquartered in Castelnau-le-Lez, France.
When was NFL Biosciences founded?
NFL Biosciences was founded in 2001.
What industry does NFL Biosciences operate in?
NFL Biosciences operates in Biotechnology, Pharmaceuticals, Healthcare.